Last update Oct. 11, 2017
Very Low Risk
Powdered carbon with high adsorption levels.
Administrated orally, it adsorbs drugs and toxins, avoiding their absorption from the gastrointestinal tract. It also has uses as an antidiarrheal and antiflatulent and for marking breast lesions in mammography.
Since the last update we have not found published data about its excretion in breast milk.
Its zero intestinal absorption (Torbet 2005, AEMPS 1998) prevents its passing into plasma and therefore into breast milk.
It use is permitted in infants under one year old (Pediamecum 2015).
We do not have alternatives for A07BA since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM